25
Participants
Start Date
December 16, 2019
Primary Completion Date
April 5, 2024
Study Completion Date
April 5, 2024
HemoCare™ Hemodialysis System
The HemoCare™ Hemodialysis System is intended for hemodialysis treatment, including short daily and nocturnal hemodialysis, of renal failure patients. The HemoCare™ Hemodialysis System is intended for use in chronic dialysis facilities, self-care dialysis facilities, or the home setting. All treatments must be prescribed by a physician and administered by a trained operator. Treatments must be performed under the supervision or assistance of a medical professional or a care partner who has been trained and deemed competent in the use of the device by the prescribing physician.
The Rogosin Institute, New York
Dialysis Clinic, Inc., Nashville
Dialysis Clinic, Inc., Knoxville
University of Mississippi Medical Center, Jackson
Wellbound South Austin, Austin
Wellbound North Austin, Austin
DCI North Brunswick, North Brunswick
Lead Sponsor
Deka Research and Development
INDUSTRY